The incidence and significance of delayed bleeding events after lower extremity revascularization in patients with advanced peripheral arterial disease
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2025.03.394 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Addiskidan Hundito und 9 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Lower Extremity, Postoperative Hemorrhage, Vascular Surgical Procedures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: National Heart Lung and Blood Institute.
Abstract (Originalsprache)
OBJECTIVE: As novel medications are used in various combinations to prevent thrombosis, few studies have focused on bleeding events after lower extremity revascularization (LER) in patients with peripheral artery disease (PAD). Moreover, the impact of bleeding events on long-term outcomes and the prescription of antithrombotic therapy is not well-reported. This study examines the incidence of bleeding events after LER and their significance in patients with advanced PAD. METHODS: A retrospective review of patients undergoing LER for PAD in a tertiary care center was performed. Bleeding was classified into major and minor based on the International Society of Thrombosis definitions and captured outside the 30-day perioperative period of LER. Characteristics and outcomes of patients who experienced bleeding events more than 30 days after initial LER were compared with patients who did not. RESULTS: A total of 1932 patients underwent LER, and 529 (27.4%) experienced a bleeding event (53% major, 47% minor) over 4.3 years. Patients who experienced a bleeding event were more likely to have hypertension (93% vs 89%; P = .005), coronary artery disease (58% vs 53%; P = .047), chronic renal insufficiency (25% vs 16%; P < .001), end-stage renal disease (12% vs 6.8%; P < .001), a history of smoking (84% vs 79%; P = .007), and be on dual antiplatelet therapy (31% vs 25%; P = .029) at baseline. Patients who experienced a bleeding event after 30 days were also more likely to have developed perioperative bleeding (7.6% vs 5.2%; P = .049) after the first LER. On follow-up, patients with bleeding were more likely to have reinterventions (51% vs 43%; P = .002), major amputation (14% vs 7.1%; P < .001), myocardial infarction (33% vs 17%; P < .001), stroke (9.5% vs 5.1%; P < .001), and mortality (48% vs 38%; P < .001). The most common type of bleeding was gastrointestinal (47%), followed by surgical site unrelated to LER (13%), and intracranial. Blood transfusion was used in 48% of patients. Moreover, 40% of patients with an initial bleeding episode had at least one recurrent bleeding episode, with a mean of 2.9 bleeding episodes per patient. After the first bleeding episode, 15% of patients were discharged without any antithrombotic therapy and 13%, 16%, and 11% had discontinuation of ASA, P2Y12 inhibitors, and anticoagulation respectively. CONCLUSIONS: Bleeding events are common after LER for advanced PAD and are associated with worse overall outcomes. Recurrent bleeding events are likely and significantly affect antithrombotic medication prescriptions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale University School of Medicine, New Haven, CT.
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, CT.
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
- Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale University School of Medicine, New Haven, CT. Electronic address: cassius.chaar@yale.edu.
Förderung
- National Heart Lung and Blood Institute
Zitieren
APA
Hundito, A., Wells, N., Tuttle, M., Alameddine, D., Huttler, J., Slade, M., Strosberg, D., Lee, A., Guzman, R. J., & Ochoa Chaar, C. I. (2025). The incidence and significance of delayed bleeding events after lower extremity revascularization in patients with advanced peripheral arterial disease. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.03.394
Vancouver
Hundito A, Wells N, Tuttle M, Alameddine D, Huttler J, Slade M, et al. The incidence and significance of delayed bleeding events after lower extremity revascularization in patients with advanced peripheral arterial disease. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.03.394
BibTeX
@article{Hundito2025,
author = {Hundito, Addiskidan and Wells, Nicholas and Tuttle, McKenzie and Alameddine, Dana and Huttler, Joshua and Slade, Martin and Strosberg, David and Lee, Alfred and Guzman, Raul J and Ochoa Chaar, Cassius Iyad},
title = {The incidence and significance of delayed bleeding events after lower extremity revascularization in patients with advanced peripheral arterial disease},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2025.03.394}
}
EUVIMED